Ntegrate Threaded Nail System
Nvision Biomedical Technologies · Decision date Oct 14, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on 14 October 2026 for the Ntegrate Threaded Nail System, submitted by Nvision Biomedical Technologies of San Antonio, Texas, under 510(k) number K261961. The filing was received on 11 June 2026 and reviewed as a traditional 510(k) by the Orthopedic panel; it was not reviewed by a third party, was not a combination product, and no predetermined change control plan was authorized.
The device falls under regulation 888.3040 with classification product code HWC, described on the record as a bone fixation screw, in the orthopedic specialty. A substantially equivalent decision means the submission was cleared to market; it is not a PMA approval. The record does not state which predicate device was cited, what components or design changes distinguish this system, or what nonclinical or clinical evidence supported the decision, so those details remain unknown from this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 14, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261961
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Nvision Biomedical Technologies
- Product code
- HWC
- Decision code
- SESE
- Decision date
- Oct 14, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Screw, Fixation, Bone.
- Applicant
- Nvision Biomedical Technologies
- Product code
- HWC
- FDA device class
- 2
FDA decision timeline
K261961 received
Application receipt date recorded by FDA.
K261961 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HWC
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| GM Dos Reis Industria e Comercio Ltda. | 510(k) clearance | Nov 2, 2026 | FDA | |
| OsteoCentric Technologies | 510(k) clearance | Oct 2, 2026 | FDA | |
Arthrex Beaming SystemK262975 | ARTHREX, INC. | 510(k) clearance | Sep 25, 2026 | FDA |
| MEDSHAPE, INC. | 510(k) clearance | Sep 23, 2026 | FDA | |
F.A.S.T ScrewK254280 | Steps Ortho | 510(k) clearance | Sep 21, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Nvision Biomedical Technologies
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- San Antonio, TX
Sources and methodology
- Original FDA record: K261961
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

